In this week's InnovationRx newsletter, federal judges halt Trump's cuts to NIH research payments, rural hospitals' ongoing ...

Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...

This article discusses the Anti-Kickback Statute and the False Claims Act. "When coupled with the False Claims Act (FCA), the AKS turns into a potent civil enforcement tool that carries many of the ...

Novartis AG agreed to buy US biotech Anthos Therapeutics for as much as $3.1 billion to gain a preventative stroke medicine ...

Novartis AG agreed to buy US biotech Anthos Therapeutics for as much as $3.1 billion to gain a preventative stroke medicine ...

The campaign, “Your Attention Please”, flips the script on society’s obsession with women’s bodies, urging women to focus on something that actually matters—early breast cancer detection. Over 6 ...

In this article, we review a number of notable Canadian trademark cases from 2024 and highlight key developments in Canadian ...

Novartis is facing patent expiries for three ... The patent expiries are a test of CEO Vas Narasimhan’s years-long overhaul of the company, with its focus narrowed to specific types of diseases.

Novartis Q4 earnings beat estimates with sales up 16%, driven by strong demand for Entresto, Kesimpta, and Cosentyx. CEO Narasimhan reportedly downplays Entresto's U.S. patent expiration ...

Hailee Steinfeld and Wanda Sykes are partnering with Novartis to encourage women to understand their breast cancer risk and get early screenings in a new ad that will air during the Super Bowl on ...

As illustrated by the two studies, Firefly’s BNA™ system can uniquely provide objective measures of treatment efficacy and cognitive change: Study 1: Advancing Neuropharmacology with Novartis ...

Novartis AG’s plan to sell its 70.6% stake in Novartis India is on track, CEO Vas Narasimhan confirmed at the World Economic Forum in Davos. Speaking to CNBC-TV18, he emphasised the company’s ...